MultiCell Technologies files patent application

ANTIBODY DRUG conjugates developed by MultiCell Technologies are designed to release drugs in their native form after the antibody drug conjugates enter the cell.
ANTIBODY DRUG conjugates developed by MultiCell Technologies are designed to release drugs in their native form after the antibody drug conjugates enter the cell.

WOONSOCKET – MultiCell Technologies recently filed a U.S. patent application to cover the company’s applications of antibody drug conjugates, medications designed to provide targeted delivery of multiple drugs from a single antibody.

As cancer therapy normally result in patients becoming ill from toxicity and off-target consequences of drugs used to treat them, taking advantage of target specificity in cancer medications is important, groundbreaking work. And it is also work that will likely be highly remunerative when it is perfected.

Antibody drug conjugates developed by MultiCell Technologies are designed to release drugs in their native form after the antibody drug conjugates enter the cell. Targeted co-delivery of medication enables the localization of both drugs within targeted cells where they exert their biological effect without the conventional collateral damage to other cells.

“We are very excited about this novel, enabling antibody-drug conjugate technology,” said W. Gerald Newmin, chairman and chief executive officer of MultiCell Technologies. “We also plan to explore other therapeutic indications, other drug combinations, and to aggressively seek partnerships with larger pharmaceutical and biotechnology companies who are interested in using ADC technology.”

- Advertisement -

MultiCell is evaluating MCT-485, is a very small noncoding double stranded RNA drug candidate in animal models of hepatocellular carcinoma. Hepatocellular carcinoma is the most common form of primary liver cancer, and is a leading cause of cancer death worldwide. More than 1 million cases of hepatocellular carcinoma are reported annually.

No posts to display